| 1 |
Ho, W. J.; Jaffee, E. M.; Zheng, L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020, 17, 527-540.
doi: 10.1038/s41571-020-0363-5
|
| 2 |
Dees, S.; Ganesan, R.; Singh, S.; Grewal, I. S. Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy. Eur J Immunol. 2021, 51, 280-291.
doi: 10.1002/eji.v51.2
URL
|
| 3 |
Majedi, F. S.; Hasani-Sadrabadi, M. M.; Thauland, T. J.; Keswani, S. G.; Li, S.; Bouchard, L. S.; Butte, M. J. Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds. Nat Biomed Eng. 2023, 7, 56-71.
doi: 10.1038/s41551-022-00977-0
|
| 4 |
Yu, A.; Dai, X.; Wang, Z.; Chen, H.; Guo, B.; Huang, L. Recent advances of mesoporous silica as a platform for cancer immunotherapy. Biosensors (Basel). 2022, 12, 109.
|
| 5 |
Nguyen, T. L.; Choi, Y.; Kim, J. Mesoporous silica as a versatile platform for cancer immunotherapy. Adv Mater. 2019, 31, e1803953.
|
| 6 |
Huang, P.; Wang, X.; Liang, X.; Yang, J.; Zhang, C.; Kong, D.; Wang, W. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater. 2019, 85, 1-26.
doi: 10.1016/j.actbio.2018.12.028
URL
|
| 7 |
Jung, K.; Corrigan, N.; Wong, E. H. H.; Boyer, C. Bioactive synthetic polymers. Adv Mater. 2022, 34, e2105063.
|
| 8 |
Marchini, A.; Gelain, F. Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine. Crit Rev Biotechnol. 2022, 42, 468-486.
doi: 10.1080/07388551.2021.1932716
URL
|
)
